UC patents that paid off
Here is a look at some of UC’s most lucrative patented inventions and products. Revenues include licensing fees, royalties and stock sales over time.
Hepatitis B vaccine: $436 million
Human growth hormone: $245 million
Treatment of intracranial aneurysms: $152 million
Bovine growth hormone: $148 million
Prostate cancer drug: $111 million
Process for splicing genes: $108 million
Immune activator for treating cancer: $88 million
EGF receptor antibodies: $77 million
Interstitial cystitis therapy: $63 million
Dynamic skin cooling device: $49 million
Chromosome painting: $44 milion
Camarosa strawberry: $41 million
Numbers rounded to the nearest million.
Source: University of California
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
